Efficacy and Safety of ETC-1002, a Novel Investigational Low-Density Lipoprotein-Cholesterol–Lowering Therapy for the Treatment of Patients With Hypercholesterolemia and Type 2 Diabetes Mellitus

Effect of Statins on Fasting Plasma Glucose in Diabetic and Nondiabetic Patients

(2016) Rishi Sukhija et al.   JOURNAL OF INVESTIGATIVE MEDICINE

ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPK

(2013) Sergey Filippov et al.   JOURNAL OF LIPID RESEARCH

Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia

(2013) Christie M. Ballantyne et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Statin Use and Risk of Diabetes Mellitus in Postmenopausal Women in the Women's Health Initiative

(2012) Annie L. Culver   ARCHIVES OF INTERNAL MEDICINE

AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism

(2012) Stephen L. Pinkosky et al.   JOURNAL OF LIPID RESEARCH

Effects of Maximal Atorvastatin and Rosuvastatin Treatment on Markers of Glucose Homeostasis and Inflammation

(2011) Nuntakorn Thongtang et al.   AMERICAN JOURNAL OF CARDIOLOGY

Atorvastatin Causes Insulin Resistance and Increases Ambient Glycemia in Hypercholesterolemic Patients

(2010) Kwang Kon Koh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Dyslipidemia treatment of patients with diabetes mellitus in a US managed care plan: a retrospective database analysis

(2009) Peter P Toth et al.   Cardiovascular Diabetology

Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care

(2008) Carolyn R Harley et al.   EXPERT OPINION ON PHARMACOTHERAPY